OrthoPediatrics Corp

Análisis de la acción OrthoPediatrics Corp (KIDS)

$24.710

+0.902 (+3.65%)Al cierre

Loading chart…
Máximo
24.990
Apertura
23.880
Precio medio ponderado por volumen
24.51
Volumen
476.36K
Capitalización
686.03M
Mínimo
23.840
Importe
11.68M
EV/EBITDA, TTM
137.25

OrthoPediatrics Corp. is an orthopedic company, which is focused on advancing the field of pediatric orthopedics. The Company is engaged in designing, developing, and marketing anatomically appropriate implants and devices for children with orthopedic conditions, giving pediatric orthopedic surgeons and caregivers. The Company sells its specialized products, including PediLoc, PediPlates, Cannulated Screws, PediFlex nail, PediNail, PediLoc Tibia, ACL Reconstruction System, Locking Cannulated Blade, Locking Proximal Femur, Spica Tables, RESPONSE Spine, BandLoc, Devise Rail, Orthex, The Fassier-Duval Telescopic Intramedullary System, SLIM Nail, The GAP Nail, The Free Gliding SCFE Screw System, GIRO Growth Modulation System, PNP Tibia System, ApiFix Mid-C System and Mitchell Ponset specialized bracing products to various hospitals and medical facilities throughout the United States and various international markets. It markets 80 surgical and specialized bracing systems.

Análisis de IA of OrthoPediatrics Corp (KIDS)

Comprar

OrthoPediatrics Corp (KIDS) is a good buy right now due to its current price of $21.95, which is below the analyst price target of $29 set by BTIG. The company has shown significant revenue growth, with Q2 revenue reaching $70.51 million, a 15.4% increase year-over-year, and a gross margin of 74%. However, the main risk is the negative earnings per share (EPS) of -0.30 reported in Q2, which reflects ongoing profitability challenges.

Recomendaciones de analistas (4)

-6.92% Potencial de caída
Comprar
4 Comprar
0 Mantener
0 Vender
Actual: 24.71
Mínimo
20.00
Promedio
23.00
Máximo
26.00

BTIG

2026-08-20

Precio objetivo

$29

Comprar

Truist

2026-08-05

Precio objetivo

$22

Mantener

Truist

2026-05-01

Precio objetivo

$17

Mantener

Canaccord

2026-04-24

Precio objetivo

$25

Comprar

Truist

2026-03-02

Precio objetivo

$20

Mantener

Métricas de valoración

El PER previsto actual de OrthoPediatrics Corp (KIDS) es 0.00, frente a su media de 5 años de -39.42.

PER previsto

Muy sobrevalorado
Media 5A P/E
-39.42
P/E actual
0.00
Sobrevalorada
-20.18
Infravalorada
-58.65

EV/EBITDA previsto

Valor razonable
Media 5A EV/EBITDA
92.05
EV/EBITDA actual
137.25
Sobrevalorada
181.18
Infravalorada
2.93

Precio/ventas previsto

Valor razonable
Media 5A P/S
4.34
P/S actual
2.07
Sobrevalorada
6.92
Infravalorada
1.76

Escenarios de precio de Alphio AI para KIDS

Los precios por escenario son la última banda de previsión mensual del año en curso. Las probabilidades son pesos fijos del modelo (25 / 50 / 25), no garantías.

A

Alcista

Alcista · 25%KIDS

$28.44

Precio del escenario

B

Base

Base · 50%KIDS

$28.41

Precio del escenario

B

Bajista

Bajista · 25%KIDS

$23.50

Precio del escenario

Ballenas con KIDS en cartera

B

Braidwell LP

+ Con en carteraKIDS

+24.21%

Rentabilidad a 3 meses

S

Soleus Capital Management, L.P.

+ Con en carteraKIDS

-5.45%

Rentabilidad a 3 meses

Cronología de eventos

2026-04-30 (ET)

17:30:00

OrthoPediatrics Launches Traxio Complete Weight System

16:40:00

OrthoPediatrics Q1 Revenue $59.36M, Exceeds Expectations

2026-02-03 (ET)

07:10:00

OrthoPediatrics Partner iotaMotion Receives FDA Clearance for Expanded Pediatric Use

2026-01-12 (ET)

07:20:00

OrthoPediatrics Projects 2026 Revenue of $262M to $266M

07:20:00

Generated Company Reports $236.1M Net Revenue for 2025

Noticias

Preguntas frecuentes sobre KIDS, respondidas por Alphio AI

OrthoPediatrics Corp. is an orthopedic company, which is focused on advancing the field of pediatric orthopedics. The Company is engaged in designing, developing, and marketing anatomically appropriate implants and devices for children with orthopedic conditions, giving pediatric orthopedic surgeons and caregivers. The Company sells its specialized products, including PediLoc, PediPlates, Cannulated Screws, PediFlex nail, PediNail, PediLoc Tibia, ACL Reconstruction System, Locking Cannulated Blade, Locking Proximal Femur, Spica Tables, RESPONSE Spine, BandLoc, Devise Rail, Orthex, The Fassier-Duval Telescopic Intramedullary System, SLIM Nail, The GAP Nail, The Free Gliding SCFE Screw System, GIRO Growth Modulation System, PNP Tibia System, ApiFix Mid-C System and Mitchell Ponset specialized bracing products to various hospitals and medical facilities throughout the United States and various international markets. It markets 80 surgical and specialized bracing systems. It operates in the Healthcare sector (SURGICAL & MEDICAL INSTRUMENTS & APPARATUS industry).

OrthoPediatrics Corp (KIDS) is a good buy right now due to its current price of $21.95, which is below the analyst price target of $29 set by BTIG. The company has shown significant revenue growth, with Q2 revenue reaching $70.51 million, a 15.4% increase year-over-year, and a gross margin of 74%. However, the main risk is the negative earnings per share (EPS) of -0.30 reported in Q2, which reflects ongoing profitability challenges.

4 analysts cover KIDS: 4 rate it Buy, 0 Hold and 0 Sell. The average price target is 23.00.

Comunidad

Más ↗

Aún no hay publicaciones

Regístrate o inicia sesión para participar

Esta página es solo para investigación y no constituye asesoramiento de inversión. Los modelos pueden equivocarse. El rendimiento pasado no garantiza resultados futuros.

Empezar a operar